Imprint Labs

IMPRINT is at the forefront of forensic immunology, developing advanced tools to read and analyze immune memory signatures. The company focuses on reconstructing immune histories from memory B cells and T cells to uncover the hidden causes of chronic diseases. By unlocking and decoding this data, IMPRINT aims to identify new disease mechanisms and therapeutic targets, facilitating the development of diagnostics, cures, and treatments. Operating within the framework of Focused Research Organizations (FROs), IMPRINT pursues ambitious scientific milestones over a finite period, typically five years, to produce high-impact public goods. The company serves the scientific and medical research community, providing them with the tools necessary to advance disease treatment. IMPRINT's business model revolves around creating experimental and computational immunology tools that can be utilized by researchers and healthcare professionals to accelerate progress in understanding and treating chronic diseases. Keywords: forensic immunology, immune memory, chronic disease, diagnostics, treatments, B cells, T cells, disease mechanisms, therapeutic targets, FROs.